Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T85943 | Target Info | |||
Target Name | Proto-oncogene c-Src (SRC) | ||||
Synonyms | pp60c-src; Tyrosine kinase (pp60(src)); Src tyrosine kinase; SRC1; Proto-oncogene tyrosine-protein kinase Src; Pp60(src); P60-Src; C-src TK; C-Src | ||||
Target Type | Successful Target | ||||
Gene Name | SRC | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 3 Acyltransferases | + | |||
Interacting Target Name | Signal transduction protein CBL (CBL) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RNF55; RING-type E3 ubiquitin transferase CBL; RING finger protein 55; Proto-oncogene c-CBL; E3 ubiquitin-protein ligase CBL; C-Cbl; CBL2; Casitas B-lineage lymphoma proto-oncogene | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [3] | |||
4 | Affinity Capture-Western | [4] | |||
5 | Affinity Capture-Western | [5] | |||
6 | Affinity Capture-Western | [6] | |||
7 | Biochemical Activity | [7] | |||
8 | Reconstituted Complex | [8] | |||
9 | Reconstituted Complex | [4] | |||
Interacting Target Name | TNF receptor-associated factor 6 (TRAF6) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RNF85; RING-type E3 ubiquitin transferase TRAF6; RING finger protein 85; Interleukin-1 signal transducer; E3 ubiquitin-protein ligase TRAF6 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [9] | |||
2 | Reconstituted Complex | [10] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase CBL-C (CBLC) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CBL.3; CBL.SL; RNF57 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [11] | |||
2 | Reconstituted Complex | [12] | |||
Carbon-nitrogen hydrolases | [+] 1 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | Histone deacetylase 3 (HDAC3) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SMAP45; RPD3-2; RPD32; HD3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Affinity Capture-Western | [14] | |||
3 | Biochemical Activity | [13] | |||
Kinases | [+] 8 Kinases | + | |||
Interacting Target Name | Focal adhesion kinase 1 (FAK) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein-tyrosine kinase 2; Protein phosphatase 1 regulatory subunit 71; PPP1R71; pp125FAK; p125FAK; FRNK; Focal adhesion kinase-related nonkinase; FAK1; FADK 1; FADK | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [15] | |||
2 | Affinity Capture-Western | [16] | |||
3 | Affinity Capture-Western | [17] | |||
4 | Co-localization | [18] | |||
5 | Reconstituted Complex | [19] | |||
6 | Yeast two hybrid | [20] | |||
Interacting Target Name | Erbb2 tyrosine kinase receptor (HER2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine kinase-type cell surface receptor HER2; Tyrosine kinase receptor ErbB2; Receptor tyrosine-protein kinase erbB-2; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; P185erbB2; NGL; NEU proto-oncogene; NEU; MLN19; MLN 19; Metastatic lymph node gene 19 protein; HER2/neu; HER2 (erbB2/neu); HER-2; Erb2; Epidermal growth factor receptor 2; C-erbB-2 oncoprotein; C-erbB-2; CD340 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Affinity Capture-Western | [22] | |||
3 | Affinity Capture-Western | [23] | |||
4 | Reconstituted Complex | [24] | |||
Interacting Target Name | Ephrin type-B receptor 2 (EPHB2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein kinase TYRO5; Tyrosine-protein kinase receptor EPH-3; TYRO5; Renal carcinoma antigen NY-REN-47; Receptor protein-tyrosine kinase HEK5; hEK5; ERK; EPTH3; EPHT3; EPH-like kinase 5; EphB2 receptor tyrosine kinase; EphB2; EPH tyrosine kinase 3; ELK-related tyrosine kinase; EK5; DRT; Developmentally-regulated Eph-related tyrosine kinase | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [25] | |||
2 | Reconstituted Complex | [26] | |||
3 | Reconstituted Complex | [25] | |||
4 | Yeast two hybrid | [25] | |||
Interacting Target Name | Activated CDC42 kinase 1 (ACK-1) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine kinase non-receptor protein 2; Tyrosine kinase nonreceptor protein 2; ACK-1; ACK1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [27] | |||
2 | Reconstituted Complex | [28] | |||
3 | Reconstituted Complex | [29] | |||
4 | Reconstituted Complex | [30] | |||
Interacting Target Name | Focal adhesion kinase 2 (PTK2B) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Related adhesion focal tyrosine kinase; RAFTK; PYK2; Protein-tyrosine kinase 2-beta; Proline-rich tyrosine kinase 2; FAK2; FADK 2; Cell adhesion kinase beta; Calcium-regulated non-receptor proline-rich tyrosine kinase; Calcium-dependent tyrosine kinase; CAK-beta; CAKB; CADTK | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Affinity Capture-Western | [32] | |||
3 | Reconstituted Complex | [33] | |||
4 | Reconstituted Complex | [32] | |||
Interacting Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Epidermal growth factor receptor variant III; Proto-oncogene c-ErbB-1 variant III; Receptor tyrosine-protein kinase erbB-1 variant III; EGFR variant III; ERBB variant III; ERBB1 variant III; HER1 variant III | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Protein-Fragment Complementation Assay | [34] | |||
3 | Yeast two hybrid | [35] | |||
Interacting Target Name | Inhibitor of nuclear factor kappa-B kinase beta (IKKB) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Nuclear factor NF-kappa-B inhibitor kinase beta; NFKBIKB; Inhibitory kappa B kinase b; Inhibitor of nuclear factor kappa-B kinase subunit beta; IKK-beta; IKKbeta; IKK-B; IKK-2; IKK2; IkBKB; I-kappa-B-kinase beta; IkappaB kinase beta; I-kappa-B kinase 2; IkappaB kinase 2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [36] | |||
2 | Affinity Capture-Western | [37] | |||
3 | Biochemical Activity | [38] | |||
Interacting Target Name | Fyn tyrosine protein kinase (FYN) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein kinase Fyn; Src-like kinase; SLK; Proto-oncogene tyrosine-protein kinase Fyn; Proto-oncogene Syn; Proto-oncogene c-Fyn; Fyn Protooncogene Syn; Fyn p59-Fyn | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [39] | |||
2 | Protein-peptide | [40] | |||
Nuclear hormone receptors | [+] 2 Nuclear hormone receptors | + | |||
Interacting Target Name | Estrogen receptor (ESR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Oestrogen receptor alpha; Oestrogen receptor; Nuclear receptor subfamily 3 group A member 1; NR3A1; Estrogen receptor alpha; Estradiol receptor; ESR; ER-alpha; ERalpha; ER | ||||
Evidence Score (E-score) | 11 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [41] | |||
2 | Affinity Capture-Western | [42] | |||
3 | Affinity Capture-Western | [43] | |||
4 | Affinity Capture-Western | [44] | |||
5 | Affinity Capture-Western | [23] | |||
6 | Affinity Capture-Western | [45] | |||
7 | Co-localization | [46] | |||
8 | Co-localization | [47] | |||
9 | Fluorescence Resonance Energy Transfer | [48] | |||
10 | Reconstituted Complex | [49] | |||
11 | Yeast two hybrid | [42] | |||
Interacting Target Name | Vitamin D3 receptor (VDR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Vitamin D(3) receptor; Nuclear vitamin D receptor; Nuclear receptor subfamily 1 group I member 1; NR1I1; 1,25-dihydroxyvitamin D3 receptor | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [50] | |||
2 | Co-localization | [51] | |||
3 | Reconstituted Complex | [52] | |||
4 | Yeast two hybrid | [53] | |||
Transcription regulators | [+] 3 Transcription regulators | + | |||
Interacting Target Name | Signal transducer and activator of transcription 3 (STAT3) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor STAT3; Stat3; Signal transducer and activator of transcription 3; APRF; Acute-phase response factor | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [54] | |||
2 | Affinity Capture-Western | [55] | |||
3 | Co-localization | [56] | |||
4 | Reconstituted Complex | [54] | |||
Interacting Target Name | CREB-binding protein (CREBBP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CREBbinding protein; CBP | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [57] | |||
2 | Co-localization | [57] | |||
3 | Reconstituted Complex | [58] | |||
Interacting Target Name | Hypoxia-inducible factor 1 alpha (HIF-1A) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor HIF-1; PASD8; PAS domain-containing protein 8; MOP1; Member of PAS protein 1; Hypoxia-inducible transcription factor (HIF)-1; Hypoxia-inducible factor 1-alpha; Hypoxia-inducible factor 1; Hypoxia inducible factor 1; HIF-1-alpha; HIF-1alpha; HIF1-alpha; HIF-1 alpha; HIF1 alpha; Class E basic helix-loop-helix protein 78; bHLHe78; Basic-helix-loop-helix-PAS protein MOP1; ARNT-interacting protein; ARNT interacting protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [57] | |||
2 | Co-localization | [56] | |||
Other proteins | [+] 6 Other proteins | + | |||
Interacting Target Name | GAP-associated tyrosine phosphoprotein p62 (KHDRBS1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Src-associated in mitosis 68 kDa protein; Srcassociated in mitosis 68 kDa protein; Sam68; p68; p21 Ras GTPase-activating protein-associated p62; p21 Ras GTPaseactivating proteinassociated p62; KH domain-containing, RNA-binding, signal transduction-associated protein 1; KH domaincontaining, RNAbinding, signal transductionassociated protein 1; GAPassociated tyrosine phosphoprotein p62 | ||||
Evidence Score (E-score) | 11 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [59] | |||
2 | Affinity Capture-Western | [60] | |||
3 | Affinity Capture-Western | [61] | |||
4 | Affinity Capture-Western | [62] | |||
5 | Biochemical Activity | [63] | |||
6 | Biochemical Activity | [64] | |||
7 | Biochemical Activity | [9] | |||
8 | Fluorescence Resonance Energy Transfer | [59] | |||
9 | Protein-peptide | [59] | |||
10 | Reconstituted Complex | [65] | |||
11 | Yeast two hybrid | [66] | |||
Interacting Protein Name | Breast cancer anti-estrogen resistance protein 1 (BCAR1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CAS; CAS1; CASS1; CRKAS; P130Cas | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [67] | |||
2 | Affinity Capture-Western | [27] | |||
3 | Affinity Capture-Western | [68] | |||
4 | Affinity Capture-Western | [69] | |||
5 | Biochemical Activity | [70] | |||
6 | Reconstituted Complex | [67] | |||
7 | Reconstituted Complex | [19] | |||
Interacting Target Name | Mucin-1 (MUC1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumour-associated antigen mucin 1; Tumor-associated mucin; Tumor-associated epithelial membraneantigen; Tumor-associated epithelial membrane antigen; PUM; Polymorphic epithelial mucin; PEMT; PEM; Peanut-reactive urinary mucin; Mucin-1; MUC-1; Krebs von den Lungen-6; KL-6; H23AG; Episialin; EMA; CD227 antigen; CD227; Carcinoma-associated mucin; Cancer antigen 15-3; CA 15-3; Breast carcinoma-associated antigen DF3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Biochemical Activity | [71] | |||
2 | Reconstituted Complex | [71] | |||
3 | Reconstituted Complex | [72] | |||
Interacting Target Name | Extracellular matrix receptor III (CD44) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Phagocytic glycoprotein I; Phagocytic glycoprotein 1; PGP-I; PGP-1; MIC4; MDU3; MDU2; LHR; Hyaluronate receptor; HUTCH-I; Hermes antigen; Heparan sulfate proteoglycan; GP90 lymphocyte homing/adhesion receptor; Extracellular matrix receptor-III; Epican; ECMR-III; CDw44; CD44 antigen | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [73] | |||
2 | Co-localization | [74] | |||
3 | Reconstituted Complex | [73] | |||
Interacting Target Name | Wiskott-Aldrich syndrome protein (WAS) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WASp; IMD2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [75] | |||
2 | Reconstituted Complex | [75] | |||
3 | Reconstituted Complex | [76] | |||
Interacting Target Name | Epithelial cadherin (CDH1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Uvomorulin; UVO; E-cadherin gene; E-cadherin; CDHE; CD324; CAM 120/80; Cadherin-1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [77] | |||
2 | Proximity Label-MS | [78] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment. Cell Signal. 2010 Mar;22(3):377-85. | ||||
REF 2 | A dynamic constitutive and inducible binding of c-Cbl by PLCgamma1 SH3 and SH2 domains (negatively) regulates antigen receptor-induced PLCgamma1 activation in lymphocytes. Exp Cell Res. 2003 Sep 10;289(1):184-94. | ||||
REF 3 | Identification and functional characterization of an Src homology domain 3 domain-binding site on Cbl. FEBS J. 2006 Dec;273(23):5442-56. | ||||
REF 4 | Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways. J Biol Chem. 1995 Jun 16;270(24):14347-51. | ||||
REF 5 | SH3P2 in complex with Cbl and Src. FEBS Lett. 2004 May 7;565(1-3):33-8. | ||||
REF 6 | Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis. Proc Natl Acad Sci U S A. 2006 May 2;103(18):7036-41. | ||||
REF 7 | PI3-kinase/Akt-dependent antiapoptotic signaling by the PDGF alpha receptor is negatively regulated by Src family kinases. FEBS Lett. 2006 Dec 22;580(30):6769-76. | ||||
REF 8 | The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation. Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6439-44. | ||||
REF 9 | TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell. 1999 Dec;4(6):1041-9. | ||||
REF 10 | TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia. J Biol Chem. 2012 May 11;287(20):16132-45. | ||||
REF 11 | Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c. J Biochem. 2012 Nov;152(5):487-95. | ||||
REF 12 | Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation. Oncogene. 2004 Mar 4;23(9):1645-55. | ||||
REF 13 | Histone deacetylase 3 localizes to the plasma membrane and is a substrate of Src. Oncogene. 2006 Jul 27;25(32):4495-500. | ||||
REF 14 | c-Src/histone deacetylase 3 interaction is crucial for hepatocyte growth factor dependent decrease of CXCR4 expression in highly invasive breast tu... Mol Cancer Res. 2007 Aug;5(8):833-45. | ||||
REF 15 | Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples. Cancer Res. 2002 May 1;62(9):2699-707. | ||||
REF 16 | Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms. Biol Reprod. 2013 Mar 28;88(3):77. | ||||
REF 17 | Analysis of FAK-associated signaling pathways in the regulation of cell cycle progression. FEBS Lett. 2000 Dec 15;486(3):275-80. | ||||
REF 18 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 19 | Protein tyrosine phosphatase-PEST regulates focal adhesion disassembly, migration, and cytokinesis in fibroblasts. J Cell Biol. 1999 Mar 8;144(5):1019-31. | ||||
REF 20 | Phospho-tyrosine dependent protein-protein interaction network. Mol Syst Biol. 2015 Mar 26;11(3):794. | ||||
REF 21 | Degradation of HER2 by Cbl-based chimeric ubiquitin ligases. Cancer Res. 2007 Sep 15;67(18):8716-24. | ||||
REF 22 | Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation. Cancer Cell. 2010 Nov 16;18(5):423-35. | ||||
REF 23 | C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells. BMC Cancer. 2018 May 2;18(1):507. | ||||
REF 24 | ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner. J Biol Chem. 2002 Oct 11;277(41):38486-93. | ||||
REF 25 | Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region. Oncogene. 1998 May;16(20):2657-70. | ||||
REF 26 | Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses. Oncogene. 2000 Jan 13;19(2):177-87. | ||||
REF 27 | Ack1 mediates Cdc42-dependent cell migration and signaling to p130Cas. J Biol Chem. 2006 Dec 8;281(49):37527-35. | ||||
REF 28 | Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2. J Biol Chem. 2009 Mar 20;284(12):8185-94. | ||||
REF 29 | Biochemical properties of the Cdc42-associated tyrosine kinase ACK1. Substrate specificity, authphosphorylation, and interaction with Hck. J Biol Chem. 2003 Nov 28;278(48):47713-23. | ||||
REF 30 | The Cdc42-associated kinase ACK1 is not autoinhibited but requires Src for activation. Biochem J. 2011 Apr 15;435(2):355-64. | ||||
REF 31 | Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular Ca2+, PYK-2, and p60(src). J Biol Chem. 2000 Apr 28;275(17):12619-25. | ||||
REF 32 | A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature. 1996 Oct 10;383(6600):547-50. | ||||
REF 33 | Negative regulation of PYK2/related adhesion focal tyrosine kinase signal transduction by hematopoietic tyrosine phosphatase SHPTP1. J Biol Chem. 1999 Oct 22;274(43):30657-63. | ||||
REF 34 | The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nat Methods. 2014 May;11(5):585-92. | ||||
REF 35 | In silico prediction of physical protein interactions and characterization of interactome orphans. Nat Methods. 2015 Jan;12(1):79-84. | ||||
REF 36 | c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression. J Biol Chem. 2003 Mar 14;278(11):9944-52. | ||||
REF 37 | Functional role of c-Src in IL-1-induced NF-kappa B activation: c-Src is a component of the IKK complex. J Biochem. 2005 Feb;137(2):189-97. | ||||
REF 38 | Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation. Mol Pharmacol. 2004 Dec;66(6):1465-77. | ||||
REF 39 | An acidic extracellular pH disrupts adherens junctions in HepG2 cells by Src kinases-dependent modification of E-cadherin. J Cell Biochem. 2009 Nov 1;108(4):851-9. | ||||
REF 40 | Identification of novel human WW domain-containing proteins by cloning of ligand targets. J Biol Chem. 1997 Jun 6;272(23):14611-6. | ||||
REF 41 | Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J. 2000 Oct 16;19(20):5406-17. | ||||
REF 42 | Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment. J Mol Endocrinol. 2004 Feb;32(1):307-23. | ||||
REF 43 | Epidermal growth factor directs sex-specific steroid signaling through Src activation. J Biol Chem. 2007 Apr 6;282(14):10697-706. | ||||
REF 44 | Binding of the ER and ARNT1 AF2 domains to exon 21 of the SRC1 isoform SRC1e is essential for estrogen- and dioxin-related transcription. J Cell Sci. 2012 Apr 15;125(Pt 8):2004-16. | ||||
REF 45 | The modified human DNA repair enzyme O(6)-methylguanine-DNA methyltransferase is a negative regulator of estrogen receptor-mediated transcription upon alkylation DNA damage. Mol Cell Biol. 2001 Oct;21(20):7105-14. | ||||
REF 46 | Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells. Nat Commun. 2013;4:2443. | ||||
REF 47 | The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription. EMBO J. 2006 Sep 20;25(18):4223-33. | ||||
REF 48 | PKA-induced resistance to tamoxifen is associated with an altered orientation of ERalpha towards co-activator SRC-1. EMBO J. 2007 Aug 8;26(15):3534-44. | ||||
REF 49 | The nuclear receptor coactivator PGC-1alpha exhibits modes of interaction with the estrogen receptor distinct from those of SRC-1. J Mol Biol. 2005 Apr 15;347(5):921-34. | ||||
REF 50 | A novel bile acid-activated vitamin D receptor signaling in human hepatocytes. Mol Endocrinol. 2010 Jun;24(6):1151-64. | ||||
REF 51 | Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res. 2006 Jan 24;34(2):543-54. | ||||
REF 52 | Dynamic and ligand-selective interactions of vitamin D receptor with retinoid X receptor and cofactors in living cells. Mol Pharmacol. 2011 Dec;80(6):1147-55. | ||||
REF 53 | Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Mol Endocrinol. 2003 Nov;17(11):2320-8. | ||||
REF 54 | Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol Cell Biol. 1996 Apr;16(4):1595-603. | ||||
REF 55 | A functional nuclear epidermal growth factor receptor, SRC and Stat3 heteromeric complex in pancreatic cancer cells. PLoS One. 2011 May 5;6(5):e19605. | ||||
REF 56 | HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene. 2005 Apr 28;24(19):3110-20. | ||||
REF 57 | Role of CBP in regulating HIF-1-mediated activation of transcription. J Cell Sci. 2005 Jan 15;118(Pt 2):301-11. | ||||
REF 58 | Targeting Lyn tyrosine kinase through protein fusions encompassing motifs of Cbp (Csk-binding protein) and the SOCS box of SOCS1. Biochem J. 2012 Mar 15;442(3):611-20. | ||||
REF 59 | Comprehensive analysis of interactions between the Src-associated protein in mitosis of 68 kDa and the human Src-homology 3 proteome. PLoS One. 2012;7(6):e38540. | ||||
REF 60 | UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug. Oncogene. 2002 Mar 27;21(13):2037-50. | ||||
REF 61 | Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. J Immunol. 2008 Jul 15;181(2):1288-98. | ||||
REF 62 | Ras GTPase-activating protein-associated p62 is a major v-Src-SH3-binding protein. FEBS Lett. 1997 Feb 10;403(1):35-9. | ||||
REF 63 | Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. J Biol Chem. 2004 Aug 27;279(35):36259-67. | ||||
REF 64 | Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62. Cell. 1992 May 1;69(3):551-8. | ||||
REF 65 | Sam68 from an immortalised B-cell line associates with a subset of SH3 domains. FEBS Lett. 1996 Jul 1;389(2):141-4. | ||||
REF 66 | A human protein-protein interaction network: a resource for annotating the proteome. Cell. 2005 Sep 23;122(6):957-68. | ||||
REF 67 | The role of SRC-CAS interactions in cellular transformation: ectopic expression of the carboxy terminus of CAS inhibits SRC-CAS interaction but has no effect on cellular transformation. Mol Carcinog. 1999 Sep;26(1):20-31. | ||||
REF 68 | p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells. J Cell Sci. 2004 Mar 15;117(Pt 8):1603-11. | ||||
REF 69 | Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b. Cancer Res. 2006 Jul 15;66(14):7007-15. | ||||
REF 70 | Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell. 2006 Dec 1;127(5):1015-26. | ||||
REF 71 | The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin. J Biol Chem. 2001 Mar 2;276(9):6061-4. | ||||
REF 72 | The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J Biol Chem. 2001 Sep 21;276(38):35239-42. | ||||
REF 73 | CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J Biol Chem. 2001 Mar 9;276(10):7327-36. | ||||
REF 74 | Direct reprogramming of stem cell properties in colon cancer cells by CD44. EMBO J. 2011 Jun 24;30(15):3186-99. | ||||
REF 75 | Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases. Curr Biol. 1996 Aug 1;6(8):981-8. | ||||
REF 76 | Identification of regions of the Wiskott-Aldrich syndrome protein responsible for association with selected Src homology 3 domains. J Biol Chem. 1996 Oct 18;271(42):26291-5. | ||||
REF 77 | Loss of cell-cell contact is induced by integrin-mediated cell-substratum adhesion in highly-motile and highly-metastatic hepatocellular carcinoma cells. Lab Invest. 2000 Mar;80(3):387-94. | ||||
REF 78 | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. Sci Signal. 2014 Dec 2;7(354):rs7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.